Depressive symptoms in stable chronic schizophrenia: prevalence and relationship to psychopathology and treatment

被引:104
作者
Baynes, D
Mulholland, C
Cooper, SJ
Montgomery, RC
MacFlynn, G
Lynch, G
Kelly, C
King, DJ
机构
[1] Queens Univ Belfast, Dept Mental Hlth, Belfast BT9 7BL, Antrim, North Ireland
[2] Queens Univ Belfast, Dept Therapeut & Pharmacol, Belfast BT7 1NN, Antrim, North Ireland
关键词
akathisia; depression; schizophrenia; social support;
D O I
10.1016/S0920-9964(99)00205-4
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
The prevalence and correlates of the depressive syndrome were explored in a population of 120 patients with stable, chronic schizophrenia living in the community. The presence of clinically significant depressive symptoms was defined by a score of 17 or greater on the Beck Depression Inventory. Patients were examined to assess severity of schizophrenic symptoms and medication side-effects. Sixteen of the 120 patients (13.3%) had significant depressive symptoms. Depressive symptoms were significantly correlated with the hostility/suspiciousness (P<0.0001), the positive symptom (P=0.0009) factor of the BPRS and with scores on the Significant Others Scale, a measure of patients' perceived lack of social support (P=0.0004). The association between depression and akathisia approached significance (P=0.007). There was no correlation with demographic variables, alcohol intake, antipsychotic dosage or anticholinergic dosage. Using a scale that rates the subjective aspects of the depressive syndrome, we found no evidence of a relationship between depression and negative symptoms in this population. These results indicate that persistent depressive symptoms in stable patients in the community are related to the degree of persistent positive psychotic symptoms, patient perceptions of social support and, weakly, to the degree of akathisia but not other aspects of antipsychotic treatment. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:47 / 56
页数:10
相关论文
共 56 条
[41]   PREDICTORS OF THERAPEUTIC BENEFIT FROM AMITRIPTYLINE IN MILD DEPRESSION - A GENERAL-PRACTICE PLACEBO-CONTROLLED TRIAL [J].
PAYKEL, ES ;
HOLLYMAN, JA ;
FREELING, P ;
SEDGWICK, P .
JOURNAL OF AFFECTIVE DISORDERS, 1988, 14 (01) :83-95
[42]   THE DEVELOPMENT OF A MEASURE OF SOCIAL SUPPORT - THE SIGNIFICANT OTHERS (SOS) SCALE [J].
POWER, MJ ;
CHAMPION, LA ;
ARIS, SJ .
BRITISH JOURNAL OF CLINICAL PSYCHOLOGY, 1988, 27 :349-358
[43]   DEPRESSION, PARKINSONIAN SYMPTOMS, AND NEGATIVE SYMPTOMS IN SCHIZOPHRENICS TREATED WITH NEUROLEPTICS [J].
PROSSER, ES ;
CSERNANSKY, JG ;
KAPLAN, J ;
THIEMANN, S ;
BECKER, TJ ;
HOLLISTER, LE .
JOURNAL OF NERVOUS AND MENTAL DISEASE, 1987, 175 (02) :100-105
[44]   GUIDELINES FOR THE DOSAGE OF NEUROLEPTICS .1. CHLORPROMAZINE EQUIVALENTS OF ORALLY-ADMINISTERED NEUROLEPTICS [J].
REY, MJ ;
SCHULZ, P ;
COSTA, C ;
DICK, P ;
TISSOT, R .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1989, 4 (02) :95-104
[45]   AKINESIA - POORLY RECOGNIZED DRUG-INDUCED EXTRAPYRAMIDAL BEHAVIORAL DISORDER [J].
RIFKIN, A ;
QUITKIN, F ;
KLEIN, DF .
ARCHIVES OF GENERAL PSYCHIATRY, 1975, 32 (05) :672-674
[46]  
ROY A, 1986, PSYCHIAT CLIN N AM, V9, P193
[47]   DEPRESSION IN CHRONIC-SCHIZOPHRENIA [J].
ROY, A ;
THOMPSON, R ;
KENNEDY, S .
BRITISH JOURNAL OF PSYCHIATRY, 1983, 142 (MAY) :465-470
[48]  
Simpson G M, 1970, Acta Psychiatr Scand Suppl, V212, P11
[49]   FLUPHENAZINE DECANOATE DOSE AND SEVERITY OF DEPRESSION IN PATIENTS WITH POST-PSYCHOTIC DEPRESSION [J].
SIRIS, SG ;
STRAHAN, A ;
MANDELI, J ;
COOPER, TB ;
CASEY, E .
SCHIZOPHRENIA RESEARCH, 1988, 1 (01) :31-35
[50]   ASSESSMENT AND TREATMENT OF DEPRESSION IN SCHIZOPHRENIA [J].
SIRIS, SG .
PSYCHIATRIC ANNALS, 1994, 24 (09) :463-467